HOME › DRUGS › TORIPALIMAB
ACTIVE SUBSTANCE / INN

TORIPALIMAB

Brand name(s): Loqtorzi
EMA LISTED
AUTHORISED
Nasopharyngeal Carcinoma;Esophageal Squamous Cell Carcinoma
ACTIVE SUBSTANCE
Toripalimab
REGULATORS
EMA
SPONSORS / MAH
Topalliance Biosciences Europe Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LoqtorziTopalliance Biosciences Europe LimitedAuthorised19/09/2024Nasopharyngeal Carcinoma;Esophageal Squamous Cell Carcinoma

FULL INTELLIGENCE ON TORIPALIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →